{"product_id":"tofidence-tocilizumab","title":"Tofidence (Tocilizumab)","description":"\u003cp\u003eTofidence® (Tocilizumab-bavi) sold under the brand name 施瑞立® in china, is a monoclonal antibody that binds to interlukin-6 receptors and is used to treat various inflammatory autoimmune conditions, including rheumatoid arthritis, polyarticular juvenile idiopathic arthritis and systemic juvenile idiopathic arthritis.\u003c\/p\u003e\u003cp\u003eOct. 8, 2023，Bio-Thera Solutions, Ltd (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of biosimilars and innovative assets, announced that its partner Biogen recently received notification from the United States Food and Drug Administration (FDA) on the approval of TOFIDENCE (tocilizumab-bavi) intravenous formulation, a biosimilar monoclonal antibody referencing ACTEMRA. \u003c\/p\u003e","brand":"Bio-Thera Solutions, China","offers":[{"title":"Default Title","offer_id":44797952294955,"sku":"RL23202402","price":0.0,"currency_code":"AMD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0701\/3528\/3755\/files\/2024-01-22100.png?v=1787022172","url":"https:\/\/xomeds.com\/products\/tofidence-tocilizumab","provider":"XOMEDS","version":"1.0","type":"link"}